0001607062-18-000347.txt : 20181015 0001607062-18-000347.hdr.sgml : 20181015 20181015161614 ACCESSION NUMBER: 0001607062-18-000347 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181003 FILED AS OF DATE: 20181015 DATE AS OF CHANGE: 20181015 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FLETCHER MARK CENTRAL INDEX KEY: 0001229529 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 181122383 MAIL ADDRESS: STREET 1: 4145 NORTH SERVICE ROAD, SUITE 200 CITY: BURLINGTON STATE: A6 ZIP: L7L6A3 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 10102 USA TODAY WAY CITY: MIRAMAR STATE: FL ZIP: 33025 BUSINESS PHONE: 416-364-2551 MAIL ADDRESS: STREET 1: 10102 USA TODAY WAY CITY: MIRAMAR STATE: FL ZIP: 33025 4 1 ownership.xml X0306 4 2018-10-03 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001229529 FLETCHER MARK 10102 USA TODAY WAY MIRAMAR FL 33025 0 1 0 0 EVP General Counsel &Secretary Common Stock 15625 D Stock Option (right to buy) 2.23 2018-10-03 4 A 0 4500 0 A 2028-10-03 Common Stock 4500 4500 D The option vests in three equal annual installments beginning on October 3, 2018. /s/ Mark A. Fletcher 2018-10-15